News & Analysis on Clinical Trial Services & Contract Research And Development
The Tri-Institutional Therapeutics Discovery Institute, Inc. will use ChemDiv's proprietary discovery chemistry platform to advance its research and development (R&D) pipeline.
Marken’s new online tool enables patients to track home deliveries of clinical trial materials, which the company said will improve the direct to patient experience.
Chesapeake IRB and Schulman IRB have merged to address increasingly complex research needs and leverage mutual company strengths, says CEO.
Guangdong Zhanjiang Jimin Pharmaceutical Co. has received a warning letter from the US FDA citing cGMP violations as well as unapproved new drug and misbranding charges.
Oracle Health Sciences has launched its safety-reporting management software in China to monitor adverse events as the country’s clinical trials industry continues to grow.
Emerging countries face significant barriers to becoming API manufacturing hubs, keeping India and China the dominant suppliers to regulated pharma markets, says a Clarivate Analytics analyst.
Indian drugmaker Lupin says product supply will not be disrupted at plants in Goa and Indore hit with a combined US FDA warning letter.